OK
Oklahoma House Bill HB2787

Oklahoma 2024 Regular Session

Oklahoma House Bill HB2787 Compare Versions

OldNewDifferences
11
22
3-ENGR. S. A. TO ENGR. H. B. NO. 2787 Page 1 1
3+SENATE FLOOR VERSION - HB2787 SFLR Page 1
4+(Bold face denotes Committee Amendments) 1
45 2
56 3
67 4
78 5
89 6
910 7
1011 8
1112 9
1213 10
1314 11
1415 12
1516 13
1617 14
1718 15
1819 16
1920 17
2021 18
2122 19
2223 20
2324 21
2425 22
2526 23
2627 24
2728
28-ENGROSSED SENATE AMENDMENT
29-TO
30-ENGROSSED HOUSE
31-BILL NO. 2787 By: Stinson of the House
29+SENATE FLOOR VERSION
30+April 13, 2023
31+
32+
33+COMMITTEE SUBSTITUTE
34+FOR ENGROSSED
35+HOUSE BILL NO. 2787 By: Stinson of the House
3236
3337 and
3438
3539 Rogers of the Senate
3640
3741
3842
3943
40-[ stem cell research - information collection and
41-reporting duties of the State Department of Health
42-- effective date ]
4344
44-
45-
46-AMENDMENT NO. 1. Page 1, strike the stricken title, enacting clause
47-and entire bill and insert
48-
49-
50-“An Act relating to public health; amending 63 O.S.
51-2021, Section 1-270.2, which relates to stem cell
52-research; modifying time period of certain report;
53-and providing an effective date.
45+[ public health - stem cell research - report -
46+effective date ]
5447
5548
5649
5750
5851 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
5952 SECTION 1. AMENDATORY 63 O.S. 2021, Section 1-270.2, is
6053 amended to read as follows:
6154 Section 1-270.2 A. For the purposes of the Advan cement in Stem
6255 Cell Cures and Therapies Act, “human embryo” means a living organism
6356 of the species Homo sapiens at the earliest stage of developme nt,
6457 including the single -cell stage, that is not located in the body of
6558 a woman.
59+B. Research on human tissue regeneration and human diseases
60+using adult stem cells an d stem cells obtained from umbilical cord
61+blood and amniotic fluid may be conducted in th is state, provided
62+that the research is performed:
63+1. Safely and ethically;
6664
67-ENGR. S. A. TO ENGR. H. B. NO. 2787 Page 2 1
65+SENATE FLOOR VERSION - HB2787 SFLR Page 2
66+(Bold face denotes Committee Amendments) 1
6867 2
6968 3
7069 4
7170 5
7271 6
7372 7
7473 8
7574 9
7675 10
7776 11
7877 12
7978 13
8079 14
8180 15
8281 16
8382 17
8483 18
8584 19
8685 20
8786 21
8887 22
8988 23
9089 24
9190
92-B. Research on human tissue regeneration and human diseases
93-using adult stem cells an d stem cells obtained from umbilical cord
94-blood and amniotic fluid may be conducted i n this state, provided
95-that the research is performed:
96-1. Safely and ethically;
97-2. Only on embryonic stem cell l ines created prior to August 1,
98-2001, and in accordance w ith federal law as it existed on November
99-1, 2007; and
100-3. Without the use of a human embryo, including a human embryo
101-produced using cloning technology.
102-C. When research is performed in accordance with the
103-Advancement in Stem Cell Cures and Therapies Act , a person or
104-governmental body shall not:
105-1. Restrict public funds designated for t he stem cell research;
106-or
107-2. Obstruct or provide disincentives for the stem cell
108-research.
109-D. The State Department of Health shall establish a reporting
110-system that collects information regarding all activities carried
111-out in accordance with this section .
112-E. The Department shall submit a report with all information
113-collected pursuant to subsection D of t his section to the Governor,
114-the Speaker of the Oklahoma House of Representatives, and the
115-
116-ENGR. S. A. TO ENGR. H. B. NO. 2787 Page 3 1
117-2
118-3
119-4
120-5
121-6
122-7
123-8
124-9
125-10
126-11
127-12
128-13
129-14
130-15
131-16
132-17
133-18
134-19
135-20
136-21
137-22
138-23
139-24
140-
141-President Pro Tempore of the State Senate no later than Decemb er 31
142-of each year every fifth year.
143-SECTION 2. This act shall become effective Novemb er 1, 2023.”
144-
145-
146-Passed the Senate the 20th day of April, 2023.
147-
148-
149-
150- Presiding Officer of the Senate
151-
152-
153-Passed the House of Representatives the ____ day of __________,
154-2023.
155-
156-
157-
158- Presiding Officer of the House
159- of Representatives
160-
161-ENGR. H. B. NO. 2787 Page 1 1
162-2
163-3
164-4
165-5
166-6
167-7
168-8
169-9
170-10
171-11
172-12
173-13
174-14
175-15
176-16
177-17
178-18
179-19
180-20
181-21
182-22
183-23
184-24
185-
186-ENGROSSED HOUSE
187-BILL NO. 2787 By: Stinson of the House
188-
189- and
190-
191- Rogers of the Senate
192-
193-
194-
195-
196-
197-
198-[ stem cell research - information collection and
199-reporting duties of the State Department of Health
200-- effective date ]
201-
202-
203-
204-
205-
206-
207-BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
208-SECTION 3. AMENDATORY 63 O.S. 2021, Section 1-270.2, is
209-amended to read as follows:
210-Section 1-270.2 A. For the purposes of the Advancement in Stem
211-Cell Cures and Therapies Act, "human embryo" means a living organism
212-of the species Homo sapiens at the earliest stage of development,
213-including the single-cell stage, that is not located in the body of
214-a woman.
215-B. Research on human tissue regeneration and human diseases
216-using adult stem cells and ste m cells obtained from umbilical cord
217-blood and amniotic fluid may be conducted in this state, provided
218-that the research is performed:
219-
220-ENGR. H. B. NO. 2787 Page 2 1
221-2
222-3
223-4
224-5
225-6
226-7
227-8
228-9
229-10
230-11
231-12
232-13
233-14
234-15
235-16
236-17
237-18
238-19
239-20
240-21
241-22
242-23
243-24
244-
245-1. Safely and ethica lly;
24691 2. Only on embryonic stem cell l ines created prior to August 1,
24792 2001, and in accordance w ith federal law as it existed on November
24893 1, 2007; and
24994 3. Without the use of a human emb ryo, including a human embryo
25095 produced using cloning technology.
25196 C. When research is performed in accordance with the
25297 Advancement in Stem Cell Cures and Therapies Act , a person or
25398 governmental body shall not:
25499 1. Restrict public funds designated for the s tem cell research;
255100 or
256101 2. Obstruct or provide disincentives for the stem cell
257102 research.
258103 D. The State Department of Health shall establish a reporting
259104 system that collects information regarding all activities carried
260105 out in accordance with this section.
261106 E. The Department shall submit a report with all information
262107 collected pursuant to subsection D of t his section to the Governor,
263108 the Speaker of the Oklahoma House of Representatives, and the
264109 President Pro Tempore of the State Senate no later than December 3 1
265-of each year.
266-SECTION 4. This act shall become effect ive November 1, 2023.
267-
268-
269-ENGR. H. B. NO. 2787 Page 3 1
270-2
271-3
272-4
273-5
274-6
275-7
276-8
277-9
278-10
279-11
280-12
281-13
282-14
283-15
284-16
285-17
286-18
287-19
288-20
289-21
290-22
291-23
292-24
293-
294- Passed the House of Representatives the 23rd day of March, 2023.
295-
296-
297-
298-
299- Presiding Officer of the House
300- of Representatives
301-
302-
303-
304-Passed the Senate the ___ day of _________, 2023.
305-
306-
307-
308-
309- Presiding Officer of the Senate
310-
311-
312-
110+of each year every fifth year.
111+SECTION 2. This act shall become effective Novemb er 1, 2023.
112+COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVI CES
113+April 13, 2023 - DO PASS AS AMENDED BY CS